Ieq Capital LLC Acquires 2,817 Shares of Humana Inc. (NYSE:HUM)

Ieq Capital LLC boosted its holdings in shares of Humana Inc. (NYSE:HUM) by 75.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,553 shares of the insurance provider’s stock after buying an additional 2,817 shares during the quarter. Ieq Capital LLC’s holdings in Humana were worth $2,448,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Hsbc Holdings PLC raised its stake in shares of Humana by 17.9% in the 2nd quarter. Hsbc Holdings PLC now owns 435,018 shares of the insurance provider’s stock valued at $163,093,000 after acquiring an additional 65,936 shares in the last quarter. CCLA Investment Management lifted its stake in shares of Humana by 1.0% in the second quarter. CCLA Investment Management now owns 316,913 shares of the insurance provider’s stock worth $115,257,000 after buying an additional 3,227 shares during the last quarter. Vanguard Personalized Indexing Management LLC lifted its stake in shares of Humana by 36.8% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 12,015 shares of the insurance provider’s stock worth $4,399,000 after buying an additional 3,229 shares during the last quarter. Tredje AP fonden boosted its holdings in shares of Humana by 124.2% during the 2nd quarter. Tredje AP fonden now owns 27,253 shares of the insurance provider’s stock worth $10,183,000 after buying an additional 15,100 shares during the period. Finally, Meiji Yasuda Asset Management Co Ltd. grew its stake in Humana by 6.3% in the 2nd quarter. Meiji Yasuda Asset Management Co Ltd. now owns 2,502 shares of the insurance provider’s stock valued at $935,000 after buying an additional 149 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

HUM has been the topic of several research analyst reports. Royal Bank of Canada raised their price target on Humana from $385.00 to $400.00 and gave the company an “outperform” rating in a research report on Thursday, September 5th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $395.00 price target on shares of Humana in a research report on Friday. Deutsche Bank Aktiengesellschaft increased their price objective on Humana from $341.00 to $349.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Robert W. Baird assumed coverage on shares of Humana in a report on Thursday, May 30th. They issued a “neutral” rating and a $374.00 price target for the company. Finally, Oppenheimer boosted their target price on shares of Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a research note on Thursday, August 1st. Thirteen analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $398.70.

Humana Stock Down 0.5 %

NYSE:HUM opened at $310.41 on Friday. Humana Inc. has a 1 year low of $298.61 and a 1 year high of $530.54. The stock has a 50-day moving average price of $357.71 and a two-hundred day moving average price of $345.61. The stock has a market cap of $37.40 billion, a price-to-earnings ratio of 19.33, a PEG ratio of 2.56 and a beta of 0.50. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.70.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The business had revenue of $29.54 billion during the quarter, compared to analysts’ expectations of $28.52 billion. During the same period in the prior year, the business earned $8.94 EPS. Humana’s revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, equities analysts expect that Humana Inc. will post 16 earnings per share for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be given a $0.885 dividend. The ex-dividend date is Monday, September 30th. This represents a $3.54 annualized dividend and a yield of 1.14%. Humana’s dividend payout ratio is currently 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.